Literature DB >> 11984497

Intraosseous pleomorphic adenoma: case report and review of the literature.

L M Aver-De-Araujo1, S B Chaves-Tarquinio, A P Neuzling-Gomes, A Etges.   

Abstract

Pleomorphic adenoma is the most common neoplasm of the salivary glands, affecting mainly the parotid gland. The preferential intraoral site of this tumor is the palate. A case of a 31-year-old woman with an intraosseous pleomorphic adenoma located in the maxilla (left paramedian region), showing an approximate evolution of one year is reported. The present intraosseous case represents a rare location, with the tumor probably originating from glandular epithelial remnants captured during embryogenesis. In a review of the literature of 142 cases of intragnathic localization (24% in the maxilla) are identified. A slight predominance of women was observed (56%), with 55% of the patients being affected during the 5th to 7th decade of life. The tumors were malignant in 94% of the cases, with special predominance of mucoepidermoid carcinoma (65%). Intraosseous pleomorphic adenomas are rare, with the present patient being the 6th case reported in the literature and the second found in the maxilla. Mean age of the 5 previously reported cases was 58.8 years.

Entities:  

Mesh:

Year:  2002        PMID: 11984497

Source DB:  PubMed          Journal:  Med Oral        ISSN: 1137-2834


  3 in total

Review 1.  Metastasizing Pleomorphic Adenoma Case Report and Review of the Literature.

Authors:  Rana Alshagroud; Amandip Kamoh; Saurin R Popat; Margaret Brandwein-Weber; Alfredo Aguirre
Journal:  Head Neck Pathol       Date:  2017-05-25

2.  Atypical Presentation of an Upper Lip Pleomorphic Adenoma: Case Report.

Authors:  Fotios Tzermpos; Chara Chatzichalepli; Alina Cocos; Manthos Kleftogiannis; Marissa Zarakas; Evanthia Chrysomali
Journal:  Acta Stomatol Croat       Date:  2014-03

3.  Pleomorphic adenoma of the cervical heterotopic salivary gland: a case report.

Authors:  Saman Vegari; Masoud Naderpour; Alireza Hemmati; Hosein Baybordi
Journal:  Case Rep Otolaryngol       Date:  2012-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.